eFFECTOR Therapeutics Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 22
Employees
  • Stock Symbol
  • EFTR
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $17.86
  • (As of Monday Closing)

eFFECTOR Therapeutics General Information

Description

eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs). Its product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The eIF4F complex is a central node where two of the most frequently mutated signaling pathways in cancer, the PI3K-AKT, and RAS-MEK pathways, converge to activate the translation of select mRNA into proteins that are frequent culprits in key disease-driving processes.

Contact Information

Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 11120 Roselle Street
  • Suite A
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

eFFECTOR Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

eFFECTOR Therapeutics Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$17.86 $19.30 $8.52 - $40.42 $785M 40.7M 4.97M
Public Fundamental Data provided by Morningstar, Inc. disclaimer

eFFECTOR Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore eFFECTOR Therapeutics‘s full profile, request access.

Request a free trial

eFFECTOR Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore eFFECTOR Therapeutics‘s full profile, request access.

Request a free trial

eFFECTOR Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new c
Drug Discovery
San Diego, CA
22 As of 2021
00000
000000000 00000

00000 00

r sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna
0000000000000
Pittsburgh, PA
0 As of 0000
00.000
0000000000 0 00.000

0000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Du
0000000000000
London, Canada
00 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

eFFECTOR Therapeutics Competitors (67)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sharp Edge Labs Venture Capital-Backed Pittsburgh, PA 0 00.000 0000000000 0 00.000
0000000 Corporation London, Canada 00 000.00 00000000 000.00
00000 000 Venture Capital-Backed Oxford, United Kingdom 00 000.00 00000000000 000.00
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
000000000 Formerly VC-backed Tucson, AZ 00 000.00 000000&0 000.00
You’re viewing 5 of 67 competitors. Get the full list »

eFFECTOR Therapeutics Executive Team (13)

Name Title Board Seat Contact Info
Stephen Worland Ph.D Chief Executive Officer & Board Member
Michael Byrnes Chief Financial Officer, Finance & Secretary, Administration
Alana McNulty Executive
Davide Ruggero Ph.D Co-Founder
Debra Vallner Ph.D Vice President of Development Operations
You’re viewing 5 of 13 executive team members. Get the full list »

eFFECTOR Therapeutics Board Members (15)

Name Representing Role Since
Brian Gallagher Ph.D Self Chairman & Board Member 000 0000
David Maki JD Altitude Life Science Ventures Board Member 000 0000
Denis Patrick Ph.D Pfizer Ventures Board Member 000 0000
John Smither Self Board Member 000 0000
Jonathan Root MD US Venture Partners Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

eFFECTOR Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

eFFECTOR Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore eFFECTOR Therapeutics‘s full profile, request access.

Request a free trial

eFFECTOR Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000 000000 27-May-2021 000000000000000000 Special Purpose Acquisition Company (SPAC) 0000000 0000000 00.0
To view eFFECTOR Therapeutics’s complete acquisitions history, request access »